Abstract
Introduction: Children's Oncology Group (COG) is the largest pediatric clinical trials group, with more than 240 participating hospitals. Today, almost 90% of all childhood cancers in North America are treated on a COG protocol. For the first time in 30 years, retinoblastoma treatment protocols are open and enrolling patients. This workshop was developed in conjunction with the leadership of the Retinoblastoma Committee at COG, and was presented, in part, to pediatric oncologists at their American Society of Pediatric Hematology/Oncology (ASPHO) meeting in April, 2008.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
